Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus

Janine M. Trevillyan, Carlee Moser, Judith S. Currier, Tamer Sallam

Research output: Contribution to journalArticleResearchpeer-review


In a retrospective case control analysis, following adjustments for high-sensitivity C-reactive protein (hsCRP), traditional cardiovascular risk factors, and the CD4/CD8 T-cell ratio, higher lipopolysaccharide-binding protein (LBP) was associated with future myocardial infarctions in hsCRP human immunodeficiency virus (HIV). LBP may be a marker of cardiovascular risk with utility in HIV.

Original languageEnglish
Pages (from-to)1764-1767
Number of pages4
JournalClinical Infectious Diseases
Issue number8
Publication statusPublished - 10 Apr 2020


  • acute myocardial infarction
  • cardiovascular disease
  • HIV
  • immune activation
  • inflammation

Cite this